A study on osteosarcoma indicated that TRIM2 may affect the proliferation, migration, and invasion of osteosarcoma cells through the PI3K/AKT signaling pathway and that high TRIM2 expression is associated with a low survival rate and promotion of metastasis. The gene discussed is AKT1; the disease is osteosarcoma.